Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00222443
What this trial is testing

Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

Who this might be right for
LymphomasTumors
University of Oklahoma 40
Testing effectiveness (Phase 2)Looking for participantsNCT04689347
What this trial is testing

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03483038
What this trial is testing

The Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Florida 45
Testing effectiveness (Phase 2)UnknownNCT06197438
What this trial is testing

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 36
Not applicableStudy completedNCT01039506
What this trial is testing

An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo Co., Ltd. 1,376
Testing effectiveness (Phase 2)Study completedNCT00856830
What this trial is testing

Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive Stage Lung CancerChemonaive
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819019
What this trial is testing

A Phase II Study of Irinotecan Liposome Plus Fruquintinib and Sintilimab in Second-Line PD-L1-Positive Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmsGastric Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07397819
What this trial is testing

Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy

Who this might be right for
Malignant Ascites
Dong sheng Zhang 48
Not applicableStudy completedNCT03504618
What this trial is testing

Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI

Who this might be right for
Colorectal Cancer
Hanoi Medical University 39
Testing effectiveness (Phase 2)Study completedNCT00569790
What this trial is testing

Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 53
Testing effectiveness (Phase 2)Study completedNCT00153998
What this trial is testing

Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Who this might be right for
Colorectal CancerLiver Metastases
Technische Universität Dresden 135
Early research (Phase 1)Not Yet RecruitingNCT06710821
What this trial is testing

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Who this might be right for
Solid Tumor Cancer
Yizhuo Zhang 40
Testing effectiveness (Phase 2)Study completedNCT00806663
What this trial is testing

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Central European Society for Anticancer Drug Research 22
Large-scale testing (Phase 3)Study completedNCT01550055
What this trial is testing

Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Zhangjiang Biotechnology Limited Company 512
Testing effectiveness (Phase 2)Looking for participantsNCT07328425
What this trial is testing

Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS

Who this might be right for
Desmoplastic Small Round Cell Tumor
Italian Sarcoma Group 20
Early research (Phase 1)Ended earlyNCT06509906
What this trial is testing

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 3
Testing effectiveness (Phase 2)UnknownNCT00931840
What this trial is testing

EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Enzon Pharmaceuticals, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT00062374
What this trial is testing

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Gastric AdenocarcinomaStage II Gastric CancerStage III Gastric Cancer+1 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT06405490
What this trial is testing

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Who this might be right for
Nanoliposomal IrinotecanCadonilimabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Post-approval studies (Phase 4)Active Not RecruitingNCT07020468
What this trial is testing

Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Affiliated Cancer Hospital of Shantou University Medical College 57
Next Page